These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28917572)

  • 21. [DFPP in myasthenia gravis: case report].
    Altobelli C; Pollastro RM; Marano E; Capasso G; Anastasio P
    G Ital Nefrol; 2015; 32(1):. PubMed ID: 25774582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-filtration plasmapheresis for the treatment of patients with recalcitrant atopic dermatitis.
    Kim JY; Park JS; Park JC; Kim ME; Nahm DH
    Ther Apher Dial; 2013 Dec; 17(6):631-7. PubMed ID: 24330559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmapheresis for hypertriglyceridemia: The association between blood viscosity and triglyceride clearance rate.
    Wu HC; Lee LC; Wang WJ
    J Clin Lab Anal; 2019 Feb; 33(2):e22688. PubMed ID: 30320483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
    Yu X; Ma J; Tian J; Jiang S; Xu P; Han H; Wang L
    J Clin Rheumatol; 2007 Aug; 13(4):193-8. PubMed ID: 17762452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hemorheologic findings in hyperviscosity syndrome and their modification by plasmapheresis].
    Pawlow I; Pardemann G; Matthes H
    Beitr Infusionsther; 1992; 30():315-9. PubMed ID: 1284724
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioisotope blood volume measurement in hemodialysis patients.
    Puri S; Park JK; Modersitzki F; Goldfarb DS
    Hemodial Int; 2014 Apr; 18(2):406-14. PubMed ID: 24262029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A case report of double-filtration plasmapheresis for the treatment of age-related macular degeneration.
    Yeh JH; Cheng CK; Chiu HC
    Ther Apher Dial; 2008 Dec; 12(6):500-4. PubMed ID: 19140849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of double filtration plasmapheresis on nocturnal respiratory function in myasthenic patients.
    Yeh JH; Lin CM; Chen WH; Chiu HC
    Artif Organs; 2013 Dec; 37(12):1076-9. PubMed ID: 23865547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of membrane trapping in plasma fractionator on separative characteristics.
    Mineshima M; Agishi T; Hasuo Y; Kaneko I; Era K; Ota K
    Int J Artif Organs; 1988 May; 11(3):191-4. PubMed ID: 3403057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double filtration plasmapheresis can decrease factor XIII Activity.
    Hanafusa N; Kondo Y; Suzuki M; Nakao A; Noiri E; Fujita T
    Ther Apher Dial; 2007 Jun; 11(3):165-70. PubMed ID: 17497996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double filtration plasmapheresis enhances neutrophil chemotactic responses in hyperimmunoglobulin E syndrome.
    Yamada H; Nagaoka I; Takamori K; Ogawa H
    Artif Organs; 1995 Jan; 19(1):98-102. PubMed ID: 7741649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to improve clotting factors depletion in double-filtration plasmapheresis.
    Naciri Bennani H; Marlu R; Terrec F; Motte L; Seyve L; Chevallier E; Malvezzi P; Jouve T; Rostaing L; Noble J
    J Clin Apher; 2021 Oct; 36(5):766-774. PubMed ID: 34339059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane cascade plasmapheresis: theoretical analysis and in vitro studies.
    Shettigar UR; Kolff WJ; Anstall HB
    Uremia Invest; 1984; 8(1):25-34. PubMed ID: 6495472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double filtration plasmapheresis in antibody-incompatible kidney transplantation.
    Higgins R; Lowe D; Hathaway M; Lam FT; Kashi H; Tan LC; Imray C; Fletcher S; Chen K; Krishnan N; Hamer R; Zehnder D; Briggs D
    Ther Apher Dial; 2010 Aug; 14(4):392-9. PubMed ID: 20649760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
    Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y
    Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced blood-to-tissue albumin movement after plasmapheresis.
    Stahl AM; Gillen CM; Takamata A; Nadel ER; Mack GW
    Shock; 2003 May; 19(5):440-7. PubMed ID: 12744487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of plasma levels of soluble CD40 ligand in systemic lupus erythematosus patients who have undergone plasmapheresis.
    Kimura K; Tsuda H; Kwangseok Y; Tamura N; Kanai Y; Kobayashi S
    Ther Apher Dial; 2005 Feb; 9(1):64-8. PubMed ID: 15828909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased factor XIII activity in a patient with subcutaneous bleeding after double filtration plasmapheresis.
    Seishima M; Shibuya Y; Kato G; Aoki T
    Ther Apher Dial; 2009 Jun; 13(3):229-31. PubMed ID: 19527471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of post-transplant double filtration plasmapheresis on recurrent focal and segmental glomerulosclerosis in renal transplant recipients.
    Otsubo S; Tanabe K; Shinmura H; Ishikawa N; Tokumoto T; Hattori M; Ito K; Nitta K; Akiba T; Nihei H; Toma H
    Ther Apher Dial; 2004 Aug; 8(4):299-304. PubMed ID: 15274681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double filtration plasmapheresis in the treatment of pancreatitis due to severe hypertriglyceridemia.
    Galán Carrillo I; Demelo-Rodriguez P; Rodríguez Ferrero ML; Anaya F
    J Clin Lipidol; 2015; 9(5):698-702. PubMed ID: 26350817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.